Remarkably, mutations in both BRAF and PTEN have been frequently observed to co-occur at high rates in melanoma, whereas NRAS mutations have been found to be mutually exclusive with BRAF and PTEN mutations [113–115]. Here, PTEN is linked to melanoma.